Interesting the C1 Fund is offering $1.12 per security, quite a bit more than PM? A review of the last capital raise at Animoca saw the shares sell at $4.50. CI Fund is offering to acquire the shares at $1.12.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
